Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method
Open Access
- 1 January 2005
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (2) , 208-211
- https://doi.org/10.3748/wjg.v11.i2.208
Abstract
AIM: To predict the HLA-A2-restricted CTL epitopes of tumor antigens associated with hepatocellular carcinoma (HCC). METHODS: MAGE-1, MAGE-3, MAGE-8, P53 and AFP were selected as objective antigens in this study for the close association with HCC. The HLA-A*0201 restricted CTL epitopes of objective tumor antigens were predicted by SYFPEITHI prediction method combined with the polynomial quantitative motifs method. The threshold of polynomial scores was set to -24. RESULTS: The SYFPEITHI prediction values of all possible nonamers of a given protein sequence were added together and the ten high-scoring peptides of each protein were chosen for further analysis in primary prediction. Thirty-five candidates of CTL epitopes (nonamers) derived from the primary prediction results were selected by analyzing with the polynomial method and compared with reported CTL epitopes. CONCLUSION: The combination of SYFPEITHI prediction method and polynomial method can improve the prediction efficiency and accuracy. These nonamers may be useful in the design of therapeutic peptide vaccine for HCC and as immunotherapeutic strategies against HCC after identified by immunology experiment.Keywords
This publication has 25 references indexed in Scilit:
- Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitroCancer Letters, 2004
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewHepatology, 2002
- Immunotherapy of hepatocellular carcinomaExpert Opinion on Biological Therapy, 2002
- Two complementary methods for predicting peptides binding major histocompatibility complex moleculesJournal of Molecular Biology, 1997
- Tolerance to p53 by A2.1-restricted Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1997
- New methods to predict MHC-binding sequences within protein antigensCurrent Opinion in Immunology, 1995
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.The Journal of Experimental Medicine, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991